Affymax to Present at RBC Capital Markets Healthcare Conference - PR-Inside.com (Pressemitteilung) PDF Print

Affymax"s product candidate, Hematide?, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ...

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.